Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 12020489)


High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients.

Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H.

Cardiol Res Pract. 2014;2014:269604. doi: 10.1155/2014/269604. Epub 2014 Aug 28.


Effect of yoga therapy on heart rate, blood pressure and cardiac autonomic function in heart failure.

Krishna BH, Pal P, G K P, J B, E J, Y S, M G S, G S G.

J Clin Diagn Res. 2014 Jan;8(1):14-6. doi: 10.7860/JCDR/2014/7844.3983. Epub 2014 Jan 12.


Changes in brain natriuretic peptide are correlated with changes in global end-diastolic volume index.

Zhang Z, Ni H, Lu B, Xu X.

J Thorac Dis. 2013 Apr;5(2):156-60. doi: 10.3978/j.issn.2072-1439.2012.11.05.


Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.

Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, Uriel N, Cotter G.

Heart Fail Rev. 2012 Mar;17(2):177-90. doi: 10.1007/s10741-011-9261-3. Review.


Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.

Noveanu M, Breidthardt T, Potocki M, Reichlin T, Twerenbold R, Uthoff H, Socrates T, Arenja N, Reiter M, Meissner J, Heinisch C, Stalder S, Mueller C.

Crit Care. 2011;15(1):R1. doi: 10.1186/cc9398. Epub 2011 Jan 5.


High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia.

Antonelli A, Ferri C, Ferrari SM, Galetta F, Franzoni F, Santoro G, De Marco S, Ghiri E, Fallahi P.

World J Gastroenterol. 2009 Oct 28;15(40):5074-9.


Ultrafiltration should not replace diuretics for the initial treatment of acute decompensated heart failure.

Shin JT, Dec GW.

Circ Heart Fail. 2009 Sep;2(5):505-11. doi: 10.1161/CIRCHEARTFAILURE.109.862474. No abstract available.


Management strategies for stage-D patients with acute heart failure.

Feldman D, Menachemi DM, Abraham WT, Wexler RK.

Clin Cardiol. 2008 Jul;31(7):297-301. Review.


Evaluation of B-type natriuretic peptide for validation of a heart failure register in primary care.

Bhatia GS, Sosin MD, Stubley J, Patel JV, Hughes EA, Gibbs R, Davis RC.

BMC Cardiovasc Disord. 2007 Jul 30;7:23.


Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Arnold JM, Howlett JG, Dorian P, Ducharme A, Giannetti N, Haddad H, Heckman GA, Ignaszewski A, Isaac D, Jong P, Liu P, Mann E, McKelvie RS, Moe GW, Parker JD, Svendsen AM, Tsuyuki RT, O'Halloran K, Ross HJ, Rao V, Sequeira EJ, White M.

Can J Cardiol. 2007 Jan;23(1):21-45. Review.


The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.

Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, Johnston JI, Smellie WS, Duffy V, Cawley P.

Br J Gen Pract. 2006 May;56(526):327-33.


Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones.

Braun MU, Rauwolf T, Zerm T, Schulze M, Schnabel A, Strasser RH.

Heart. 2005 May;91(5):601-5.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk